H. Toriyama-baba et al., Organotropic chemopreventive effects of n-3 unsaturated fatty acids in a rat multi-organ carcinogenesis model, JPN J CANC, 92(11), 2001, pp. 1175-1183
Organotropic chemopreventive effects of n-3 unsaturated fatty acids were st
udied using a multiorgan carcinogenesis model in male rats. Rats were treat
ed with diethylnitrosamine (DEN), N-methyl-N-nitrosourea (MNU), N-butyl-N-4
-hydroxybutylnitrosamine (BBN), 1,2-dimethylhydrazine (DMH) and dihydroxy-d
i-n-propylnitrosamine (DHPN) during the first 7 weeks, and then given unsat
urated fatty acid (UFAs), docosahexaenoic acid (n-3, C-22:6) (DHA), eicosap
entaenoic acid (n-3, C-20:5) (EPA), linoleic acid (n-6, C-18:2) (LA) or ole
ic acid (n-9, C-18:1) (OA) at a dose of 1.0 ml/rat, 3 times a week by gavag
e for the consecutive 30 weeks. All rats were fed a low LA basal diet throu
ghout the experiment and a calorie-restricted basal diet during the period
of UFAs feeding administration. DHA significantly reduced tumor size and nu
mbers in the large intestine as compared to OA treatment. Furthermore, DHA
showed a tendency to inhibit carcinogenesis in the small intestine and lung
. EPA also showed a tendency to inhibit intestinal carcinogenesis. On the o
ther hand, LA showed a tendency to inhibit lung carcinogenesis, but to prom
ote large intestinal carcinogenesis. However these UFAs did not influence p
reneoplastic and neoplastic lesion development in the liver, kidney, and ur
inary bladder. Levels of the administered fatty acids were clearly increase
d in the serum and organs. In contrast, arachidonic acid (AA) levels in the
large and small intestines and liver were markedly decreased by treatment
with DHA and EPA. Decreased levels of AA in the large intestine correlated
well with tumor incidence, although the number of glutathione S-transferase
-positive (GST-P+) foci showed an inverse correlation with AA levels. The d
ata thus provide evidence that an organotropism exists with regard to the i
nfluence of UFAs on carcinogenesis, which correlates with reduction of tiss
ue AA levels in the target organs.